CollPlant Biotechnologies SEC Filing Effectiveness
Ticker: CLGN · Form: EFFECT · Filed: Apr 22, 2026 · CIK: 0001631487
Sentiment: neutral
Topics: sec-filing, effectiveness, registration-statement
TL;DR
CollPlant's SEC filing is now effective. Big news for their stock.
AI Summary
CollPlant Biotechnologies Ltd. filed an EFFECT form on April 22, 2026, indicating the effectiveness of a registration statement. The filing relates to Act 33 and has the file number 333-294738. The company's business address is 4 Oppenheimer St., 11th Floor, Rehovot, L3 74140.
Why It Matters
This filing signifies that a registration statement for CollPlant Biotechnologies has become effective, which is a crucial step for certain securities offerings or transactions.
Risk Assessment
Risk Level: medium — The effectiveness of an SEC filing can impact stock price and investor sentiment, but the specific implications depend on the underlying transaction.
Key Numbers
- 333-294738 — File Number (Associated with the registration statement)
- 0001631487 — CIK (CollPlant Biotechnologies Ltd identifier)
Key Players & Entities
- CollPlant Biotechnologies Ltd (company) — Filer
- 0001631487 (company) — CIK
- 333-294738 (dollar_amount) — File Number
- 2026-04-22 (date) — Filing Acceptance Date
- 2026-04-21 (date) — Effectiveness Date
FAQ
What type of registration statement has become effective for CollPlant Biotechnologies Ltd?
The filing is an EFFECT form, indicating the effectiveness of a registration statement under Act 33, with file number 333-294738.
When was this filing accepted by the SEC?
The filing was accepted on April 22, 2026.
What is the effectiveness date mentioned in the filing?
The effectiveness date is April 21, 2026.
What is the primary business of CollPlant Biotechnologies Ltd according to the SIC code?
The SIC code 3842 indicates the company is in Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Where is CollPlant Biotechnologies Ltd located?
The company's business and mailing address is 4 Oppenheimer St., 11th Floor, Rehovot, L3 74140.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 22, 2026 regarding CollPlant Biotechnologies Ltd (CLGN).